This study aims to closely examine 100 people with persisting cognitive symptoms after COVID-19, assessing the cognitive problems as well as markers of brain damage, inflammation, and underlying degenerative brain disease. Details of Papers Published to date 'What is Brain Fog?': https://jnnp.bmj.com/content/early/2022/12/06/jnnp-2022-329683 Structural epitope profiling identifies antibodies associated with critical COVID-19 and long COVID: https://www.medrxiv.org/content/10.1101/2022.07.11.22277368v2 Functional cognitive disorders: clinical presentations and treatment approaches: https://pn.bmj.com/content/early/2022/12/08/pn-2022-003608 COV/LTE/20/28 Longer term impact of COVID-19 infection people with diabetes University of Glasgow Dr Robert Lindsay £295,201 People with diabetes have suffered greater adverse consequences of COVID-19 in the acute phase of infection during the pandemic.